DEBRANAYE ROSE: Open Payments
NPI 1922604172 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,734 in 76 payments from 14 companies in 2025. Trend: 2023 $3,529 · 2024 $3,339 · 2025 $2,734
Food & beverage: $2,534Education: $200
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $423 |
| ABBVIE INC. | 14 | $385 |
| Incyte Corporation | 9 | $276 |
| Arcutis Biotherapeutics, Inc. | 2 | $231 |
| UCB, Inc. | 8 | $223 |
| Regeneron Healthcare Solutions, Inc. | 4 | $206 |
| Janssen Biotech, Inc. | 13 | $202 |
| E.R. Squibb & Sons, L.L.C. | 4 | $178 |
| GENZYME CORPORATION | 5 | $156 |
| Amgen Inc. | 1 | $133 |
Products named: OPZELURA, SKYRIZI, DUPIXENT, Zoryve, Bimzelx, TREMFYA, Sotyktu, Leqselvi.
Industry payments across NY — which companies pay providers there.
